William Blair analyst Tim Lugo reiterated an Outperform rating on Xenon Pharmaceuticals (NASDAQ: XENE).The analyst comments: "We believe the top-line ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE